Dolutegravir + Tenofovir/Emtricitabine

· ViiV Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dolutegravir + Tenofovir/Emtricitabine, covering 2019-04-18 to 2019-04-18. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) [Phase 3]

See pricing